200 related articles for article (PubMed ID: 27997436)
1. Dihydromyricetin reverses MRP2-mediated MDR and enhances anticancer activity induced by oxaliplatin in colorectal cancer cells.
Wang Z; Sun X; Feng Y; Liu X; Zhou L; Sui H; Ji Q; E Q; Chen J; Wu L; Li Q
Anticancer Drugs; 2017 Mar; 28(3):281-288. PubMed ID: 27997436
[TBL] [Abstract][Full Text] [Related]
2. Dihydromyricetin reverses MRP2-induced multidrug resistance by preventing NF-κB-Nrf2 signaling in colorectal cancer cell.
Wang Z; Sun X; Feng Y; Wang Y; Zhang L; Wang Y; Fang Z; Azami NLB; Sun M; Li Q
Phytomedicine; 2021 Feb; 82():153414. PubMed ID: 33461143
[TBL] [Abstract][Full Text] [Related]
3. [Correlation of chemosensitivity tested using histoculture drug response assay to expression of multidrug resistance genes and proteins in colorectal cancer tissues].
Yuan SQ; Zhou ZW; Liang YJ; Fu LW; Chen G; Qiu HB; Zhang LY
Ai Zheng; 2009 Sep; 28(9):932-8. PubMed ID: 19728910
[TBL] [Abstract][Full Text] [Related]
4. Evodiamine Suppresses ABCG2 Mediated Drug Resistance by Inhibiting p50/p65 NF-κB Pathway in Colorectal Cancer.
Sui H; Zhou LH; Zhang YL; Huang JP; Liu X; Ji Q; Fu XL; Wen HT; Chen ZS; Deng WL; Zhu HR; Li Q
J Cell Biochem; 2016 Jun; 117(6):1471-81. PubMed ID: 26590365
[TBL] [Abstract][Full Text] [Related]
5. [Correlation of chemosensitivity measured by histoculture drug response assay to expression of multidrug resistance genes and proteins in gastric cancer].
Yuan SQ; Zhou ZW; Liang YJ; Fu LW; Chen G; Keshari RP; Zhang LY
Ai Zheng; 2009 Apr; 28(4):337-43. PubMed ID: 19622290
[TBL] [Abstract][Full Text] [Related]
6. Combination of dihydromyricetin and ondansetron strengthens antiproliferative efficiency of adriamycin in K562/ADR through downregulation of SORCIN: A new strategy of inhibiting P-glycoprotein.
Sun Y; Liu W; Wang C; Meng Q; Liu Z; Huo X; Yang X; Sun P; Sun H; Ma X; Peng J; Liu K
J Cell Physiol; 2019 Apr; 234(4):3685-3696. PubMed ID: 30171603
[TBL] [Abstract][Full Text] [Related]
7. Targeting P-glycoprotein and SORCIN: Dihydromyricetin strengthens anti-proliferative efficiency of adriamycin via MAPK/ERK and Ca
Sun Y; Wang C; Meng Q; Liu Z; Huo X; Sun P; Sun H; Ma X; Peng J; Liu K
J Cell Physiol; 2018 Apr; 233(4):3066-3079. PubMed ID: 28681913
[TBL] [Abstract][Full Text] [Related]
8. Involvement of drug transporters in the synergistic action of FOLFOX combination chemotherapy.
Theile D; Grebhardt S; Haefeli WE; Weiss J
Biochem Pharmacol; 2009 Dec; 78(11):1366-73. PubMed ID: 19622348
[TBL] [Abstract][Full Text] [Related]
9. Novel understanding of ABC transporters ABCB1/MDR/P-glycoprotein, ABCC2/MRP2, and ABCG2/BCRP in colorectal pathophysiology.
Andersen V; Svenningsen K; Knudsen LA; Hansen AK; Holmskov U; Stensballe A; Vogel U
World J Gastroenterol; 2015 Nov; 21(41):11862-76. PubMed ID: 26557010
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of verapamil-enhanced chemosensitivity of gallbladder cancer cells to platinum drugs: glutathione reduction and MRP1 downregulation.
Wang H; Li X; Chen T; Wang W; Liu Q; Li H; Yi J; Wang J
Oncol Rep; 2013 Feb; 29(2):676-84. PubMed ID: 23229154
[TBL] [Abstract][Full Text] [Related]
11. [MiR-145 inhibits drug resistance to Oxaliplatin in colorectal cancer cells through regulating G protein coupled receptor 98].
Fu Q; Cheng J; Zhang J; Zhang Y; Chen X; Xie J; Luo S
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 May; 20(5):566-570. PubMed ID: 28534337
[TBL] [Abstract][Full Text] [Related]
12. Lupeol alters ER stress-signaling pathway by downregulating ABCG2 expression to induce Oxaliplatin-resistant LoVo colorectal cancer cell apoptosis.
Chen MC; Hsu HH; Chu YY; Cheng SF; Shen CY; Lin YJ; Chen RJ; Viswanadha VP; Lin YM; Huang CY
Environ Toxicol; 2018 May; 33(5):587-593. PubMed ID: 29436100
[TBL] [Abstract][Full Text] [Related]
13. [Reversal Effect of Dihydromyricetin on Drug Resistance of K562/A02 Cell Line to Adriamycin].
Li BR; Wang L; Han WN; Xia LQ; Tang S
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Oct; 24(5):1369-1374. PubMed ID: 27784359
[TBL] [Abstract][Full Text] [Related]
14. Aconitum alkaloids, the major components of Aconitum species, affect expression of multidrug resistance-associated protein 2 and breast cancer resistance protein by activating the Nrf2-mediated signalling pathway.
Wu JJ; Zhu YF; Guo ZZ; Lou YM; He SG; Guan Y; Zhu LJ; Liu ZQ; Lu LL; Liu L
Phytomedicine; 2018 May; 44():87-97. PubMed ID: 29277460
[TBL] [Abstract][Full Text] [Related]
15. Luteolin sensitizes two oxaliplatin-resistant colorectal cancer cell lines to chemotherapeutic drugs via inhibition of the Nrf2 pathway.
Chian S; Li YY; Wang XJ; Tang XW
Asian Pac J Cancer Prev; 2014; 15(6):2911-6. PubMed ID: 24761924
[TBL] [Abstract][Full Text] [Related]
16. Pregnane X receptor is associated with unfavorable survival and induces chemotherapeutic resistance by transcriptional activating multidrug resistance-related protein 3 in colorectal cancer.
Dong Y; Wang Z; Xie GF; Li C; Zuo WW; Meng G; Xu CP; Li JJ
Mol Cancer; 2017 Mar; 16(1):71. PubMed ID: 28356150
[TBL] [Abstract][Full Text] [Related]
17. β-Sitosterol Reverses Multidrug Resistance via BCRP Suppression by Inhibiting the p53-MDM2 Interaction in Colorectal Cancer.
Wang Z; Zhan Y; Xu J; Wang Y; Sun M; Chen J; Liang T; Wu L; Xu K
J Agric Food Chem; 2020 Mar; 68(12):3850-3858. PubMed ID: 32167760
[TBL] [Abstract][Full Text] [Related]
18. Improvement of resistance to oxaliplatin by vorinostat in human colorectal cancer cells through inhibition of Nrf2 nuclear translocation.
Tanaka S; Hosokawa M; Tatsumi A; Asaumi S; Imai R; Ogawara KI
Biochem Biophys Res Commun; 2022 Jun; 607():9-14. PubMed ID: 35358872
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of an ATP-binding cassette superfamily transporter, multidrug resistance protein 2, in human colorectal carcinomas.
Hinoshita E; Uchiumi T; Taguchi K; Kinukawa N; Tsuneyoshi M; Maehara Y; Sugimachi K; Kuwano M
Clin Cancer Res; 2000 Jun; 6(6):2401-7. PubMed ID: 10873092
[TBL] [Abstract][Full Text] [Related]
20. Resveratrol induces AMPK-dependent MDR1 inhibition in colorectal cancer HCT116/L-OHP cells by preventing activation of NF-κB signaling and suppressing cAMP-responsive element transcriptional activity.
Wang Z; Zhang L; Ni Z; Sun J; Gao H; Cheng Z; Xu J; Yin P
Tumour Biol; 2015 Dec; 36(12):9499-510. PubMed ID: 26124005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]